Stocks that helped PMSes focused on smallcaps, midcaps outperform in March
SECTIONS
Share
Synopsis
Saurabh Mukherjea, Founder, Marcellus Investment Managers, thinks Indian specialty chemicals today is where the pharma sector stood in the mid-1990s on the cusp of a golden 20-year run.
Getty Images
Some multicap PMSes, which have larger allocation to midcap and smallcap stocks, also performed well in March, continuing from the earlier months. That was even when their benchmarks finished largely flat for the month.
Related
NEW DELHI: Smallcap and midcap-focused PMS schemes outperformed their peers by a vast margin for yet another month, as the equity market favoured smaller names vis-à-vis the larger ones in March.
Stellar gains! Nearly 70% PMSes outperform Nifty in 2020; 6 funds in the red
Equirus Securities Long Horizon Fund was the top gainer in 2020, rising 61.55 percent year-on-year. January 22, 2021 / 12:34 PM IST
Calendar 2020 was a year of many firsts. The market went from record highs in the opening months to multi-year lows in March and back to record highs by the end of the year.
Despite the push and pull, the bulls managed to dig in, with the Nifty rising 14.9 percent during the year. The heavy lifting by the bulls was more apparent in the broader markets, as smallcap and midcap rose 21.9 percent and 32.1 percent, respectively. The BSE 500, often considered a proxy to corporate India, surged 16.8 percent during 2020.